Division of Bacterial Diseases (DBD) News Bulletin

Summer 2015

October 2, 2015: Content on this page kept for historical reasons.

Publication Highlights

Acosta AM, DeBolt C, Tasslimi A, et al. Tdap vaccine effectiveness in adolescents during the 2012 Washington state pertussis epidemic. Pediatrics. 2015;135(6):981–9.

Beaudoin A, Edison L, Introcaso CE, et al. Acute rheumatic fever and rheumatic heart disease among children—American Samoa, 2011–2012. MMWR. 2015;64(20):555–8.

Beer KD, Gargano JW, Roberts VA, et al. Outbreaks associated with environmental and undetermined water exposures—United States, 2011–2012. MMWR. 2015;64(31):849–51.

Burgos-Rivera B,  Lee AD, Bowden KE, et al. Evaluation of level of agreement in Bordetella species identification in three United States laboratories during a period of increased pertussis. J Clin Microbiol. 2015;53(6):1842–7.

Chalker VJ, Pereyre S, Dumke R, et al. International Mycoplasma pneumoniae typing study: Interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect. 2015;7:37–40.

Demirjian A, Lucas CE, Garrison LE, et al. The importance of clinical surveillance in detecting Legionnaires’ disease outbreaks: A large outbreak in a hospital with a Legionella disinfection system—Pennsylvania, 2011–2012. Clin Infect Dis. 2015;60(11):1596–1602.

Desai AP, Sharma D, Crispell EK, et al. Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia. Pediatr Infect Dis J. 2015 Jul 29. [Epub ahead of print]

Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015 Jul 16. [Epub ahead of print]

Folaranmi T, Rubin L, Martin SW, et al. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR. 2015;64(22):608–12.

Francois Watkins LK, Sanchez GV, Albert AP, et al. Knowledge and attitudes regarding antibiotic use among Hispanic consumers, all adult consumers, and health care providers — United States, 2012–2013. MMWR. 2015;64(28):767–70.

Gambhir M, Clark TA, Cauchemez S, et al. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015;11(4):e1004138.

Harcourt BH, Anderson RD, Wu HM, et al. Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States. Open Forum Infect Dis. 2015 Aug 13. [Epub ahead of print]

Harris AM,  Del Yazzie D, Antone-Nez R, et al. Community-acquired invasive GAS disease among Native Americans in Arizona, USA, winter 2013. Emerg Infect Dis. 2015;21(1):177–9.

Hicks LA, Bartoces MG, Roberts RM, et al. U.S. outpatient antibiotic prescribing varies according to geography, patient population, and provider specialty in 2011. Clin Infect Dis. 2015;60(9):1308–16.

Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Eng J Med. 2015;373(5):415–27.

Jones BE, Sauer B, Jones MM, et al. Variation in outpatient antibiotic prescribing for acute respiratory infections in the veteran population. Ann Intern Med. 2015 Jul 21. [Epub ahead of print]

King JC, Gao Y, Quinn CP, et al. Evaluation of anthrax vaccine safety in 18 to 20 year olds; a first step towards age de-escalation studies in adolescents. Vaccine. 2015;33(21):2470–6.

McNamara LA, Shumate AM, Johnsen P, et al. First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak. Pediatrics. 2015;135(5):798–804.

McNamara LA, Shumate AM, Johnsen Pet al. First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak. Pediatrics. 2015;135(5):798–804.

Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev. 2015;28(1):95–133.

Moore MR, Link-Gelles R, Schaffner W, et al. Impact of use of 13-valent pneumococcal conjugate vaccine used in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301–9.

Moore MR, Whitney CG. Use of pneumococcal disease epidemiology to set policy and prevent disease during 20 years of the Emerging Infections Program. Emerg Infect Dis. 2015;21(9):1151–6.

Olson D, Francois Watkins LK, Demirjian A, et al. Outbreak of Mycoplasma pneumoniae-associated Stevens-Johnson Syndrome. Pediatrics. 2015;136(2):e386–94.

Pilishvili T, Bennett NM. Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines. Vaccine. 2015 Jul 8. [Epub ahead of print]

Schiffer JM, Chen L, Dalton S, et al. Bridging non-human primate correlates of protection to reassess the anthrax vaccine adsorbed booster schedule in humans. Vaccine. 2015;33(31):3709–16.

Skoff TH, Baumbach J, Cieslak PR. Tracking pertussis and evaluating control measures through enhanced pertussis surveillance, Emerging Infections Program, United States. Emerg Infect Dis. 2015 Jul 1. [Epub ahead of print]

Soeters HM, McNamara LA, Whaley M, et al. Serogroup B meningococcal disease outbreak and carriage evaluation at a college—Rhode Island, 2015. MMWR. 2015;64(22):606–7.

Tiwari TSP, Baughman AL, Clark TA. First pertussis vaccine dose and prevention of infant mortality. Pediatrics. 2015;135(6):900–9.

Wang X, Shutt KA, Vuong JT, et al. Changes in the population structure of invasive Neisseria meningitidis in the United States after quadrivalent meningococcal conjugate vaccine licensure. J Infect Dis. 2015;211(12):1887–94.

Williams MM, Taylor TH Jr, Warshauer DM, et al. Harmonization of Bordetella pertussis real-time PCR diagnostics in the United States in 2012. J Clin Microbiol. 2015;53(1):118-23.

 Top of Page

Page last reviewed: September 28, 2015